Apple Submits a Patent Application for a Method of Non-invasive Glucose Monitoring

Apple has made progress toward its goal of producing a blood glucose monitoring system that does not require invasive surgery. An application for a patent that was published on Thursday provides some hints as to how Apple could include such technology in the Apple Watch.

Apple Insider was the one who made the discovery that the application had been submitted to the United States Patent and Trademark Office. It describes an optical system in which sensors and other equipment are built into a “compact, portable device” that can do absorption spectroscopy.

When light with specific characteristics is shone on a substance, that active ingredient will absorb the energy in proportion to the wavelengths that are emitted by the light. Because of this, the characteristics of the light will shift when you leave the room. The discrepancy can then be applied to the calculation to determine the substance’s concentration. The technology will use a wide range of specialized parts, such as light emitters, filters, beamsplitters, short-wavelength infrared (SWIR) detectors, and others, to fix any possible problems with accuracy.

Apple has been interested in the development of a non-invasive option for glucose measurements for a very long time. The personal struggles that Steve Jobs was going through in the latter years of his life, including diabetes and cancer, served as inspiration for the endeavour that the business undertook to build the sensors.

We have not yet seen any real-world success despite the fact that too many businesses have spent several years attempting to resolve the issue. Patients with diabetes still don’t have any reliable alternatives to poking holes in their skin to check their blood sugar levels.

Even while the most recent patent seems to hold a lot of promise, those of you who are holding out hope that the technology will be included in the Apple Watch Series 4 are in for a major letdown. Sources who know about the situation have said that non-invasive glucose testing won’t be available to the public as a commercial device for a few more years.

Leave a Reply